AI risk alerts, new biomarkers and expanded screening are landing on primary care physicians without added time or staff. Shifting outreach, testing coordination and closed-loop referrals to partners can help practices close the gap.
|Articles|May 20, 2021
USPSTF lowers age for recommended colorectal screenings
Author(s)Keith A. Reynolds
Colorectal screenings are now recommended for all patients between the ages of 45 years old and 75 years old.
Advertisement
The U.S. Preventive Services Task Force (USPSTF) has expanded the recommended ages for colorectal cancer screenings.
According to a
The recommended screening strategies include:
- High-sensitivity guaiac fecal occult blood test (HSgFOBT) or fecal immunochemical test (FIT) every year
- Stool DNA-FIT every 1 to 3 years
- Computed tomography colonography every 5 years
- Flexible sigmoidoscopy every 5 years
- Flexible sigmoidoscopy every 10 years + annual FIT
- Colonoscopy screening every 10 years
The task force continues to recommend that physicians selectively offer screening for the condition in patients between 76 years old and 85 years old as the net benefit of screening all members of this population is small, the statement says.
Advertisement
Related to this article
The top news stories in medicine today: The AMA moves against insurer downcoding and says AI can't be licensed as a physician; a Jacksonville pharmacy owner is indicted in a $51 million health care fraud scheme; an NIH study finds every participant carried a gene variant that can affect drug response.
What exactly is your RAF score telling you about patients and coding? Here’s why the lower-RAF score clinic might be the better coder.
Key findings from the AMGA 2026 Medical Clinic Staffing Survey
Learn what a work RVU is, how Medicare's 2027 conversion factor turns RVUs into payment and how employers use wRVUs to set physician compensation.
Is the time coming for primary care to move beyond traditional insurance? It’s worth a conversation, said a leader of the American Academy of Family Physicians.
Higher Part D deductibles, rising Medigap and Part B premiums and the end of $0-premium drug plans may lead patients to skip refills and visits early in 2027. Here’s who is most exposed, why lower utilization could mask 2028 costs and what to do before Dec. 7 and in January.
The top news stories in medicine today: The FDA approves the first factor XIa inhibitor to reduce the risk of a repeat stroke; a Queens adult day care program director pleads guilty in a $127 million Medicare and Medicaid fraud scheme; researchers tie a blood RNA signal to the precancerous stage of ovarian cancer.
Advertisement
Advertisement
Trending on Medical Economics
1
AI chatbot treatment recommendations are swayed by drug ads
2
Primary care Rx: Six ways to fix it, from the National Academy of Medicine
3
Why Medicare’s 20% modifier 25 cut still penalizes same-day care
4
How 2027 Medicare cost increases could lead patients to defer care — and what practices should do
5